KTTA · Company research
Pasithea Therapeutics Corp. (KTTA): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
15records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Pasithea Therapeutics (KTTA) Slips 3.40% to $0.41 as Micro-Cap Biotech Holds Near Support - Aggressive Growth Picks - https://www.siam.in/ | Pasithea Therapeutics (KTTA) Slips 3.40% to $0.41 as Micro-Cap Biotech Holds Near Support - Aggressive Growth Picks https://www.siam.in/ | View source ↗ | https://www.siam.in/ | Oct 15, 2026 | neutral | 0 | 0.6 |
| Pasithea Therapeutics (KTTA) Edges Lower 1.74% to $0.45 as Shares Sit Near Range Support - Single Stock ETF - www.dars.gov.et | Pasithea Therapeutics (KTTA) Edges Lower 1.74% to $0.45 as Shares Sit Near Range Support - Single Stock ETF www.dars.gov.et | View source ↗ | www.dars.gov.et | Oct 7, 2026 | neutral | 0 | 0.6 |
| Pasithea Therapeutics (NASDAQ: KTTA) says KTTAW warrants will lose all value - Stock Titan | Pasithea Therapeutics (NASDAQ: KTTA) says KTTAW warrants will lose all value Stock Titan | View source ↗ | Stock Titan | Sep 16, 2026 | neutral | 0 | 0.6 |
| Pasithea Therapeutics Slides As Insider Purchases Lose Another US$48k - Simply Wall Street | Pasithea Therapeutics Slides As Insider Purchases Lose Another US$48k Simply Wall Street | View source ↗ | Simply Wall Street | Sep 15, 2026 | neutral | 0 | 0.6 |
| A nerve-tumor drug trial’s first clinical data will be presented in Vienna this November - Stock Titan | A nerve-tumor drug trial’s first clinical data will be presented in Vienna this November Stock Titan | View source ↗ | Stock Titan | Sep 14, 2026 | neutral | 0 | 0.6 |
| Pasithea Therapeutics Receives Nasdaq Extension on Listing Compliance - The Globe and Mail | Pasithea Therapeutics Receives Nasdaq Extension on Listing Compliance The Globe and Mail | View source ↗ | The Globe and Mail | Aug 22, 2026 | neutral | 0 | 0.6 |
| New Strong Buy Stocks for July 20th - Yahoo Finance | New Strong Buy Stocks for July 20th Yahoo Finance | View source ↗ | Yahoo Finance | Jul 20, 2026 | neutral | 0 | 0.6 |
| KTTA Forecast — Price Target — Prediction for 2027 - TradingView | KTTA Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 26, 2026 | neutral | 0 | 0.6 |
| Insider Purchase: 10% owner at $KTTA Buys 100,000 Shares - Quiver Quantitative | Insider Purchase: 10% owner at $KTTA Buys 100,000 Shares Quiver Quantitative | View source ↗ | Quiver Quantitative | Jun 22, 2026 | neutral | 0 | 0.6 |
| Pasithea Therapeutics (KTTA) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance | Pasithea Therapeutics (KTTA) Could Find a Support Soon, Here's Why You Should Buy the Stock Now Yahoo Finance | View source ↗ | Yahoo Finance | Jun 10, 2026 | neutral | 0 | 0.6 |
| Is Pasithea Therapeutics (NASDAQ:KTTA) In A Good Position To Deliver On Growth Plans? - Yahoo Finance | Is Pasithea Therapeutics (NASDAQ:KTTA) In A Good Position To Deliver On Growth Plans? Yahoo Finance | View source ↗ | Yahoo Finance | May 3, 2026 | neutral | 0 | 0.6 |
| Why Did KTTA Stock Soar A Whopping 43% Today? - Stocktwits | Why Did KTTA Stock Soar A Whopping 43% Today? Stocktwits | View source ↗ | Stocktwits | Nov 28, 2025 | neutral | 0 | 0.6 |
| Pasithea Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock - Investing News Network | Pasithea Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock Investing News Network | View source ↗ | Investing News Network | Nov 28, 2025 | neutral | 0 | 0.6 |
| Pasithea’s Stock Surge: Is It Time to Invest? - StocksToTrade | Pasithea’s Stock Surge: Is It Time to Invest? StocksToTrade | View source ↗ | StocksToTrade | Nov 28, 2025 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Feb 12, 2024 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.